Jefferies Group reissued their hold rating on shares of Marrone Bio Innovations (NASDAQ:MBII) in a report issued on Wednesday morning. The brokerage currently has a $1.55 target price on the basic materials company’s stock.
A number of other brokerages also recently issued reports on MBII. Zacks Investment Research downgraded Marrone Bio Innovations from a hold rating to a sell rating in a report on Thursday, February 15th. ValuEngine downgraded Marrone Bio Innovations from a sell rating to a strong sell rating in a report on Thursday, March 1st. Finally, HC Wainwright set a $4.00 price target on Marrone Bio Innovations and gave the company a buy rating in a report on Thursday, December 21st. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has assigned a buy rating to the company. The stock has an average rating of Hold and an average target price of $2.18.
MBII stock opened at $1.95 on Wednesday. The company has a debt-to-equity ratio of -1.14, a quick ratio of 0.36 and a current ratio of 0.69. Marrone Bio Innovations has a 1-year low of $0.85 and a 1-year high of $2.30.
ILLEGAL ACTIVITY NOTICE: This news story was posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this news story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright and trademark law. The legal version of this news story can be read at https://www.tickerreport.com/banking-finance/3299410/jefferies-group-reaffirms-hold-rating-for-marrone-bio-innovations-mbii.html.
Marrone Bio Innovations Company Profile
Marrone Bio Innovations, Inc offers bio-based pest management and plant health products. The Company’s bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene.
Receive News & Ratings for Marrone Bio Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marrone Bio Innovations and related companies with MarketBeat.com's FREE daily email newsletter.